Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Frank

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|February 1, 2020
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory DeficitsAlaa Alachkar, Shreesh K Ojha, Adel Sadeq, et al.
Nano Letters|December 26, 2015
Toward Tailored All-Spin Molecular DevicesMaciej Bazarnik, Bernhard Bugenhagen, Micha Elsebach, et al.
Bioorganic & Medicinal Chemistry|June 29, 2019
Novel meriolin derivatives as rapid apoptosis inducersDaniel Drießen, Fabian Stuhldreier, Annika Frank, et al.
ACS Chemical Neuroscience|June 8, 2021
Guanidine Derivatives: How Simple Structural Modification of Histamine H<sub>3</sub>R Antagonists Has Led to the Discovery of Potent Muscarinic M<sub>2</sub>R/M<sub>4</sub>R AntagonistsMarek Staszewski, Dominik Nelic, Jakub Jończyk, et al.
International Journal of Molecular Sciences|March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in MiceNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2015
Structures of the Apo and FAD-bound forms of 2-hydroxybiphenyl 3-monooxygenase (HbpA) locate activity hotspots identified by using directed evolutionChantel N Jensen, Tamara Mielke, Joseph E Farrugia, et al.
Journal of the American Chemical Society|July 2, 2013
Engineering an enantioselective amine oxidase for the synthesis of pharmaceutical building blocks and alkaloid natural productsDiego Ghislieri, Anthony P Green, Marta Pontini, et al.
Chembiochem : a European Journal of Chemical Biology|July 2, 2013
Structure and activity of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus, which catalyses the R-selective reduction of an imine substrateMaría Rodríguez-Mata, Annika Frank, Elizabeth Wells, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2024
Histamine H<sub>3</sub> receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotectionSilvia Sgambellone, Mohammad A Khanfar, Silvia Marri, et al.
ACS Chemical Biology|July 8, 2017
Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of LigandsAnatol Schwab, Boris Illarionov, Annika Frank, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|February 1, 2020
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory DeficitsAlaa Alachkar, Shreesh K Ojha, Adel Sadeq, et al.
Nano Letters|December 26, 2015
Toward Tailored All-Spin Molecular DevicesMaciej Bazarnik, Bernhard Bugenhagen, Micha Elsebach, et al.
Bioorganic & Medicinal Chemistry|June 29, 2019
Novel meriolin derivatives as rapid apoptosis inducersDaniel Drießen, Fabian Stuhldreier, Annika Frank, et al.
ACS Chemical Neuroscience|June 8, 2021
Guanidine Derivatives: How Simple Structural Modification of Histamine H<sub>3</sub>R Antagonists Has Led to the Discovery of Potent Muscarinic M<sub>2</sub>R/M<sub>4</sub>R AntagonistsMarek Staszewski, Dominik Nelic, Jakub Jończyk, et al.
International Journal of Molecular Sciences|March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in MiceNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2015
Structures of the Apo and FAD-bound forms of 2-hydroxybiphenyl 3-monooxygenase (HbpA) locate activity hotspots identified by using directed evolutionChantel N Jensen, Tamara Mielke, Joseph E Farrugia, et al.
Journal of the American Chemical Society|July 2, 2013
Engineering an enantioselective amine oxidase for the synthesis of pharmaceutical building blocks and alkaloid natural productsDiego Ghislieri, Anthony P Green, Marta Pontini, et al.
Chembiochem : a European Journal of Chemical Biology|July 2, 2013
Structure and activity of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus, which catalyses the R-selective reduction of an imine substrateMaría Rodríguez-Mata, Annika Frank, Elizabeth Wells, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2024
Histamine H<sub>3</sub> receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotectionSilvia Sgambellone, Mohammad A Khanfar, Silvia Marri, et al.
ACS Chemical Biology|July 8, 2017
Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of LigandsAnatol Schwab, Boris Illarionov, Annika Frank, et al.
Pageof 3